Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (311-320 of 528) with videos related to

Pageof 53
Sort By:
Clinical Lung Cancer|February 9, 2023
Prognostic Role of Biologically Active Volume of Disease in Patients With Metastatic Lung AdenocarcinomaColton Ladbury, Tariq Abuali, Jason Liu, et al.
Biochemical Pharmacology|October 7, 2023
Regression of ovarian cancer xenografts by depleting or inhibiting RLIPSravani K Ramisetty, Pankaj Garg, Atish Mohanty, et al.
Journal of Clinical Pathways : the Foundation of Value-Based Care|August 28, 2019
Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment SettingCasey Mason, Peter G Ellis, Kathy Lokay, et al.
The Annals of Thoracic Surgery|July 28, 2004
Integrin-dependent protein tyrosine phosphorylation is a key regulatory event in collagen-IV-mediated adhesion and proliferation of human lung tumor cell line, Calu-1Nishit K Mukhopadhyay, David Gilchrist, Gavin J Gordon, et al.
Translational Lung Cancer Research|March 21, 2025
Novel <i>LZTR1</i> germline mutation as a mechanism of resistance to osimertinib in <i>EGFR</i>-mutated lung adenocarcinoma: a case reportWai Park, Jeremy Fricke, Isa Mambetsariev, et al.
International Journal of Medical Sciences|June 27, 2013
Lack of association of C-Met-N375S sequence variant with lung cancer susceptibility and prognosisJiunn-Min Shieh, Yen-An Tang, Tsung-Han Yang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 11, 2012
Inhibition of mitochondrial fission prevents cell cycle progression in lung cancerJalees Rehman, Hannah J Zhang, Peter T Toth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancerGautam Maulik, Takashi Kijima, Patrick C Ma, et al.
Case Reports in Clinical Pathology|December 27, 2014
Unique metastases of ALK mutated lung cancer activated to the adnexa of the uterusAllison H West, S Diane Yamada, Heber MacMahon, et al.
Clinical Lung Cancer|March 13, 2021
Improved Survival Outcomes in Medically Fit Patients With Early-Stage Non-Small-Cell Lung Cancer Undergoing Stereotactic Body RadiotherapyJason Liu, Caressa Hui, Colton Ladbury, et al.
Pageof 53

Showing results (311-320 of 528) with videos related to

Sort By:
Pageof 53
Clinical Lung Cancer|February 9, 2023
Prognostic Role of Biologically Active Volume of Disease in Patients With Metastatic Lung AdenocarcinomaColton Ladbury, Tariq Abuali, Jason Liu, et al.
Biochemical Pharmacology|October 7, 2023
Regression of ovarian cancer xenografts by depleting or inhibiting RLIPSravani K Ramisetty, Pankaj Garg, Atish Mohanty, et al.
Journal of Clinical Pathways : the Foundation of Value-Based Care|August 28, 2019
Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment SettingCasey Mason, Peter G Ellis, Kathy Lokay, et al.
The Annals of Thoracic Surgery|July 28, 2004
Integrin-dependent protein tyrosine phosphorylation is a key regulatory event in collagen-IV-mediated adhesion and proliferation of human lung tumor cell line, Calu-1Nishit K Mukhopadhyay, David Gilchrist, Gavin J Gordon, et al.
Translational Lung Cancer Research|March 21, 2025
Novel <i>LZTR1</i> germline mutation as a mechanism of resistance to osimertinib in <i>EGFR</i>-mutated lung adenocarcinoma: a case reportWai Park, Jeremy Fricke, Isa Mambetsariev, et al.
International Journal of Medical Sciences|June 27, 2013
Lack of association of C-Met-N375S sequence variant with lung cancer susceptibility and prognosisJiunn-Min Shieh, Yen-An Tang, Tsung-Han Yang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 11, 2012
Inhibition of mitochondrial fission prevents cell cycle progression in lung cancerJalees Rehman, Hannah J Zhang, Peter T Toth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancerGautam Maulik, Takashi Kijima, Patrick C Ma, et al.
Case Reports in Clinical Pathology|December 27, 2014
Unique metastases of ALK mutated lung cancer activated to the adnexa of the uterusAllison H West, S Diane Yamada, Heber MacMahon, et al.
Clinical Lung Cancer|March 13, 2021
Improved Survival Outcomes in Medically Fit Patients With Early-Stage Non-Small-Cell Lung Cancer Undergoing Stereotactic Body RadiotherapyJason Liu, Caressa Hui, Colton Ladbury, et al.
Pageof 53